Omega Fund V, L.P. - Nov 22, 2021 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
10%+ Owner
Signature
/s/ Anne-Mari Paster, as an authorized signatory of each Reporting Person
Stock symbol
NUVB
Transactions as of
Nov 22, 2021
Transactions value $
-$2,879,551
Form type
4
Date filed
11/24/2021, 05:38 PM
Previous filing
Nov 5, 2021
Next filing
Dec 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVB Common Stock Sale -$2.88M -295K -1.17% $9.76 24.9M Nov 22, 2021 Direct F1, F3
transaction NUVB Common Stock Sale -$351 -36 0% $9.75 24.9M Nov 23, 2021 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 The reported securities are held directly by Omega Fund V, L.P. ("Omega V"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. ("Omega V GP"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. ("Omega V GP Manager"), as the general partner of Omega V GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Each of Omega V GP, Omega Fund V GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any.